Advertisement

Digestive Diseases and Sciences

, Volume 50, Issue 2, pp 312–313 | Cite as

Fenofibrate-Induced Cirrhosis

  • Furqaan Ahmed
  • Lydia Petrovic
  • Ellen Rosen
  • Raimundo Gonzalez
  • Ira M. Jacobson
LETTER TO THE EDITOR

Keywords

Public Health 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. De Gennes JL, Truffert J, Periac P: Elevation des transaminases glutamopyruviques sous traitement par procetofene des hyperlipidemies idiopathiques. Frequence et importance dans 443 cas traites. Nouv Presse Med 7:2398–2399, 1978PubMedGoogle Scholar
  2. Tricor product insert. Abbott Laboratories, 2001Google Scholar
  3. Krempf M, Rohmer V, Farneir M, Issa-Sayegh M, Corda C, Sirugue I, Gerlinger C, Masseyeff-Elbaz MF: Efficacy and safety of micronised fenofibrate in a randomised double-blind study comparing four doses from 200 mg to 400 mg daily with placebo in patients with hypercholesterolemia. Diabetes Metab 26:184–191, 2000PubMedGoogle Scholar
  4. Rouhier ML, Rifflet H, Rifflet I, Oberti F, Vuillemin E, Chevailler A, Cales P: Gastroenterol Clin Biol 20(12):1137–1138, 1996PubMedGoogle Scholar
  5. Lelouch S, Pelletier G, Sinico M, Ducreux M, Etienne JP: Hepatite aigue pseudoangiocholitique au fenofibrate. Gastoenterol Clin Biol 16:597–599, 1992Google Scholar
  6. Rigal J, Furet Y, Autret E, Breteau M: Hepatite mixte severe au fenofibrate? Revue de la litterature a propos d’un cas. Rev Med Interne 10(1):65–67, 1989CrossRefPubMedGoogle Scholar
  7. Fartoux-Heymann L, Narcy-Lambare B, Labayle, Fischer D: Ann Med Interne 152(5):353–354, 2001Google Scholar
  8. Couzigou P, Boutillier P, Boisseau, Faucher P, De Mascarel A, Amouretti M, Beraud C, Boisseau A, Dangoumau J: Hepatite medicamenteuse au fenofibrate. Therapie 35(3):403, 1980PubMedGoogle Scholar
  9. Massen H, Furet Y: Hepatite au fenofibrate. Cahiers Anesthesiol 34(3):249–259, 1986Google Scholar
  10. Vachon JM: Hepatite due procetofene. Nouvelle Presse Med 9:2740, 1980Google Scholar
  11. Aron E, Metman EH, Bougnoux PH: Hepatite due au procetafene? Nouvelle Presse Med 8:783, 1979Google Scholar
  12. Chatrenet P, Regimbeau C, Raman JP, Penot J, Bruandet P: Hepatite chronique active cirrhogene au fenofibrate. Gastroenterol Clin Biol 17:612–613, 1993PubMedGoogle Scholar
  13. Bernard PH, Lanou-Liatte H, Le Bail B, Bioulac-Sage P, Quinton A, Balabaud C: Hepatite chronique active associee a des anticorps anti-noyau induite par le fenofibrate. Gastroenterol Clin Biol 18:1048–1049, 1994PubMedGoogle Scholar
  14. Punthakee Z, Scully LJ, Guindi MM, Ooi TC: Liver fibrosis attributed to lipid lowering medications: two cases. J Intern Med 250:249–254, 2001PubMedGoogle Scholar
  15. Ganne-Carrie N, Leusse A, Guettier C, Castera L, Leveq H, Bertrand HJ, Plumet Y, Trinchet JC, Beaugrand M: Hepatites d’allure auto-immune induites par les fibrates. Gastroenterol Clin Biol 22:525–529, 1998PubMedGoogle Scholar
  16. Fruchart JC, Staels B, Duriez P: The role of fibric acids in atherosclerosis. Curr Atheroscler Rep 3:83–92, 2001PubMedGoogle Scholar
  17. Homberg JC, Abuaf N, Helmy-Khalil S, Biour M, Poupon R, Islam S, Damis F, Levy VG, Opolon P, Beaugrand M, Toulet J, Danan G, Benhamou JP: Druginduced hepatitis associated with anticytoplasmic organelle autoantibodies. Hepatology 5(5):722–727, 1985PubMedGoogle Scholar
  18. Migneco G, Mascarella A, La Ferla A, Attianese R: Epatite da clofibrato. Minerva Med 77(19):799–800, 1986PubMedGoogle Scholar
  19. Dumortier J, Slim R, Chevallier M, Boillot O, Thaunat JL, Vaillant E, Vial T, Bellemin B, Paliard P, Scoazec JY: Hepatite aigue severe cirrhogene après prise de ciprofibrate. Gastroenterol Clin Biol 23:1399–1400, 1999PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, Inc. 2005

Authors and Affiliations

  • Furqaan Ahmed
    • 1
  • Lydia Petrovic
    • 2
  • Ellen Rosen
    • 3
  • Raimundo Gonzalez
    • 4
  • Ira M. Jacobson
    • 1
  1. 1.Division of Gastroenterology and HepatologyWeill Medical College of Cornell UniversityNew YorkUSA
  2. 2.Division of PathologyWeill Medical College of Cornell UniversityNew YorkUSA
  3. 3.Division of GastroenterologyMorristown Memorial HospitalMorristownUSA
  4. 4.Division of PathologyMorristown Memorial HospitalMorristownUSA

Personalised recommendations